VELCADE (bortezomib)

**Product type:** Human Prescription Drug

**Active ingredient:** BORTEZOMIB

**Strength:** 3.5 mg/1

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous; Subcutaneous

**Labeler:** Takeda Pharmaceuticals America, Inc.

**Marketing category:** NDA (NDA021602)

**Pharmacologic class:** Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]